Parameters | No. of cases (%) | Mean ± SD | Parameters | No. of cases (%) |
---|---|---|---|---|
Total | 136 | TNM stage | ||
Sex | I/II | 84 (61.8) | ||
Male | 83 (61.0) | III/IV | 52 (38.2) | |
Female | 53 (39.0) | Lymphovascular invasion (LVI) | ||
Age | 62.35 ± 14.102 | Absent | 79 (58.1) | |
< 63 | 65 (47.8) | Present | 57 (41.9) | |
≥ 63 | 71 (52.2) | Perineural invasion | ||
Tumor side | Absent | 111 (81.6) | ||
Right | 56 (41.2) | Present | 25 (18.4) | |
Left | 76 (55.9) | Metastasis | ||
Unreported | 4 (2.9) | Absent | 89 (65.4) | |
Tumor size | 5.56 ± 2.47 | Present | 34 (25.0) | |
< 5 | 56 (41.2) | Unreported | 13 (9.6) | |
≥ 5 | 78 (57.4) | Recurrence | ||
Unreported | 2 (1.5) | Absent | 97 (71.3) | |
Differentiation grade | Present | 29 (21.3) | ||
Low grade | 76 (55.9) | Unreported | 10 (7.4) | |
Moderate to high grade | 60 (44.1) | Tumor budding | ||
T stage | Low | 89 (65.4) | ||
T1/T2 | 47 (34.6) | High | 47 (34.6) | |
T3/T4 | 89 (65.4) | Tertiary lymphoid structure (TLS) | ||
Lymph node involvement | Absent | 104 (76.5) | ||
Absent | 90 (66.2) | Present | 32 (23.5) | |
Present | 46 (33.8) | Survival | ||
M stage | Alive | 79 (58.1) | ||
M0 | 124 (91.2) | Dead | 57 (41.9) | |
M1 | 12 (8.8) |